GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE

Side Effects & Adverse Event Reports


View Chart Data

26.5K

Adverse Events

128.4K

Side Effects

2007

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE.

Understanding the potential Side Effects and Adverse Events of GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE?

    SymPedia shows GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE adverse event reports for 26,455.

  • How many side effects have been reported for GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE?

    SymPedia shows GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE side effect reports for 128,363.

  • What year does the GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE reporting data start?

    SymPedia reporting data on this page starts in 2007.

  • What years are included in the yearly chart for GABLOFEN 10,000 MCG IN 20 ML (500 MCG/ML) PREFILLED SYRINGE?

    SymPedia yearly chart data on this page covers 2007 to 2025.